
Hope A. Robinson
Examiner (ID: 9182)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1656, 1652, 1653 |
| Total Applications | 1878 |
| Issued Applications | 1001 |
| Pending Applications | 305 |
| Abandoned Applications | 620 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17314919
[patent_doc_number] => 20210403967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => DIETARY FIBER PRODUCTION USING A GLYCOSYL-TRANSFERASE
[patent_app_type] => utility
[patent_app_number] => 17/280852
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4999
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/280852 | DIETARY FIBER PRODUCTION USING A GLYCOSYL-TRANSFERASE | Sep 26, 2019 | Pending |
Array
(
[id] => 17548153
[patent_doc_number] => 20220119494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => RECOMBINANT VECTOR, HOST CELL AND PROCESS FOR PRODUCTION OF HUMAN SERUM ALBUMIN
[patent_app_type] => utility
[patent_app_number] => 17/293794
[patent_app_country] => US
[patent_app_date] => 2019-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293794 | RECOMBINANT VECTOR, HOST CELL AND PROCESS FOR PRODUCTION OF HUMAN SERUM ALBUMIN | Sep 16, 2019 | Abandoned |
Array
(
[id] => 17548153
[patent_doc_number] => 20220119494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => RECOMBINANT VECTOR, HOST CELL AND PROCESS FOR PRODUCTION OF HUMAN SERUM ALBUMIN
[patent_app_type] => utility
[patent_app_number] => 17/293794
[patent_app_country] => US
[patent_app_date] => 2019-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293794 | RECOMBINANT VECTOR, HOST CELL AND PROCESS FOR PRODUCTION OF HUMAN SERUM ALBUMIN | Sep 16, 2019 | Abandoned |
Array
(
[id] => 17520768
[patent_doc_number] => 20220106617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => METHOD OF PRODUCING HIGHLY UNSATURATED FATTY ACID CONTAINING GLYCERIDES USING LIPASE HYDROLYSIS REACTION
[patent_app_type] => utility
[patent_app_number] => 17/273140
[patent_app_country] => US
[patent_app_date] => 2019-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17273140
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/273140 | Enriching DHA in glyceride fractions | Sep 3, 2019 | Issued |
Array
(
[id] => 15557517
[patent_doc_number] => 20200063170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => Isolated Codon Sequence
[patent_app_type] => utility
[patent_app_number] => 16/553447
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16553447
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/553447 | Isolated Codon Sequence | Aug 27, 2019 | Abandoned |
Array
(
[id] => 15557519
[patent_doc_number] => 20200063171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => Isolated Codon Sequence
[patent_app_type] => utility
[patent_app_number] => 16/553492
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7251
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16553492
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/553492 | Methods for increasing production of cannabinoids in yeast cells | Aug 27, 2019 | Issued |
Array
(
[id] => 17655429
[patent_doc_number] => 20220175894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => USE OF RECOMBINANT ANTIBACTERIAL ENZYME LYSSAP26 EFFECTIVELY KILLING PATHOGENIC BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/262184
[patent_app_country] => US
[patent_app_date] => 2019-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262184
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/262184 | Method of treating pathogenic bacterial infectious diseases | Aug 27, 2019 | Issued |
Array
(
[id] => 16878281
[patent_doc_number] => 11028417
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-06-08
[patent_title] => Isolated codon sequence
[patent_app_type] => utility
[patent_app_number] => 16/553103
[patent_app_country] => US
[patent_app_date] => 2019-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7369
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16553103
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/553103 | Isolated codon sequence | Aug 26, 2019 | Issued |
Array
(
[id] => 16786370
[patent_doc_number] => 10988785
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-04-27
[patent_title] => Isolated codon sequence
[patent_app_type] => utility
[patent_app_number] => 16/553120
[patent_app_country] => US
[patent_app_date] => 2019-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7374
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16553120
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/553120 | Isolated codon sequence | Aug 26, 2019 | Issued |
Array
(
[id] => 16112219
[patent_doc_number] => 20200208132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/536814
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16536814
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/536814 | RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF | Aug 8, 2019 | Abandoned |
Array
(
[id] => 15993933
[patent_doc_number] => 20200172837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => SERINE PROTEASES
[patent_app_type] => utility
[patent_app_number] => 16/532560
[patent_app_country] => US
[patent_app_date] => 2019-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16532560
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/532560 | SERINE PROTEASES | Aug 5, 2019 | Abandoned |
Array
(
[id] => 18134900
[patent_doc_number] => 11560556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-24
[patent_title] => Protein C-factor VII chimeras
[patent_app_type] => utility
[patent_app_number] => 17/265277
[patent_app_country] => US
[patent_app_date] => 2019-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 23
[patent_no_of_words] => 8559
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265277
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265277 | Protein C-factor VII chimeras | Aug 2, 2019 | Issued |
Array
(
[id] => 17141963
[patent_doc_number] => 20210309975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => BIOSYNTHETIC PLATFORM FOR THE PRODUCTION OF CANNABINOIDS AND OTHER PRENYLATED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/264758
[patent_app_country] => US
[patent_app_date] => 2019-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20730
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264758 | Biosynthetic platform for the production of cannabinoids and other prenylated compounds | Jul 31, 2019 | Issued |
Array
(
[id] => 17126505
[patent_doc_number] => 20210301273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => Non-Specific Nucleases from the Genus Pseudomonas for Use in Facilitating Flow of Cells Through a Microfluidic Channel
[patent_app_type] => utility
[patent_app_number] => 17/264748
[patent_app_country] => US
[patent_app_date] => 2019-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264748
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264748 | Non-specific nucleases from the genus | Jul 25, 2019 | Issued |
Array
(
[id] => 17938669
[patent_doc_number] => 11473113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-18
[patent_title] => cAMP receptor protein variant, coding sequence and method of producing L-amino acid using the same
[patent_app_type] => utility
[patent_app_number] => 16/633461
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7983
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16633461
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/633461 | cAMP receptor protein variant, coding sequence and method of producing L-amino acid using the same | Jul 24, 2019 | Issued |
Array
(
[id] => 18029156
[patent_doc_number] => 11512331
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-29
[patent_title] => cAMP receptor protein variant and method of producing L-amino acid using the same
[patent_app_type] => utility
[patent_app_number] => 16/644315
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7962
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16644315
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/644315 | cAMP receptor protein variant and method of producing L-amino acid using the same | Jul 24, 2019 | Issued |
Array
(
[id] => 15436249
[patent_doc_number] => 20200032308
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => FERMENTATION PROCESS FOR PRODUCING MONOSACCHARIDES IN FREE FORM FROM NUCLEOTIDE-ACTIVATED SUGARS
[patent_app_type] => utility
[patent_app_number] => 16/521054
[patent_app_country] => US
[patent_app_date] => 2019-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16521054
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/521054 | FERMENTATION PROCESS FOR PRODUCING MONOSACCHARIDES IN FREE FORM FROM NUCLEOTIDE-ACTIVATED SUGARS | Jul 23, 2019 | Abandoned |
Array
(
[id] => 15117787
[patent_doc_number] => 20190345526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => METHODS FOR STARCH HYDROLYSIS
[patent_app_type] => utility
[patent_app_number] => 16/519707
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16519707
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/519707 | Methods for starch hydrolysis | Jul 22, 2019 | Issued |
Array
(
[id] => 15321113
[patent_doc_number] => 20200000886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => ENGINEERING THE RRM2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE TO RESIST DEGRADATION
[patent_app_type] => utility
[patent_app_number] => 16/457441
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457441
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/457441 | Engineering the RRM2 subunit of ribonucleotide reductase to resist degradation | Jun 27, 2019 | Issued |
Array
(
[id] => 19580068
[patent_doc_number] => 12146168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-19
[patent_title] => Human CGAS-DNA complex and encoded protein
[patent_app_type] => utility
[patent_app_number] => 17/252454
[patent_app_country] => US
[patent_app_date] => 2019-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 54
[patent_no_of_words] => 51138
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252454 | Human CGAS-DNA complex and encoded protein | Jun 25, 2019 | Issued |